Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2025-12-26 @ 10:32 AM
NCT ID:
NCT04097028
Group ID:
EG000
Title:
Treatment (TAS-102, Oxaliplatin)
Description:
Patients receive oxaliplatin IV over 2 hours on day 1 and trifluridine and tipiracil hydrochloride PO BID on days 1-5. Treatment repeats every 14 days for 3 cycles in the absence of disease progression or unacceptable toxicity. Patients then undergo standard of care chemoradiation therapy followed by surgery.
Trifluridine and Tipiracil Hydrochloride: Given PO
Oxaliplatin: Given IV
Deaths Number Affected:
7
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
22
Other Number Affected:
17
Other Number At Risk:
22
Study:
NCT04097028
Results Section:
NCT04097028
Adverse Events Module:
NCT04097028